Cancers | Free Full-Text | Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEJM
Trastuzumab Deruxtecan for Metastatic HER2-Low Breast Cancer - NCI
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry | Breast Cancer Research | Full Text
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment | npj Breast Cancer
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2- low carcinomas and beyond - ScienceDirect
Mammakarzinom | Neue Therapiemöglichkeiten beim metastasierten HER2-low-Mammakarzinom | springermedizin.de
Overall survival in patients with advanced HER2-negative breast cancer... | Download Scientific Diagram
Cancers | Free Full-Text | Targeted Approaches to HER2-Low Breast Cancer: Current Practice and Future Directions
HER2-Low Breast Cancer: a New Subtype? | SpringerLink
Refining the definition of HER2‐low class in invasive breast cancer - Atallah - 2022 - Histopathology - Wiley Online Library
Hormone receptor status, HER2-low status, and IHC scores distributions... | Download Scientific Diagram
Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
Evolution of HER2-low expression from primary to recurrent breast cancer | npj Breast Cancer
Mammakarzinom | Neue Therapiemöglichkeiten beim metastasierten HER2-low-Mammakarzinom | springermedizin.de
HER2-low breast cancers: Current insights and future directions - ScienceDirect
Cureus | Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer | Article
Breast Cancer, Early Stage | ESMO
Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status | BMC Medicine | Full Text
Selecting patients with HER2-low breast cancer: Getting out of the tangle - ScienceDirect
Gene expression profiles of HER2-negative breast cancer according to... | Download Scientific Diagram
Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
Andrea Malfettone on Twitter: "Great recap of #HER2-low breast cancer foundational concepts by @PTarantinoMD at #ESMO22 ✓HER2-low as a no distinct prognostic entity, with no OS difference vs HER2-0 ✓HER2-low diagnosis remains
IJMS | Free Full-Text | HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?
PDF) HER2-Low Breast Cancers
Cancers | Free Full-Text | HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
